13 Apr 2020 Alnylam Pharmaceuticals (Nasdaq: ALNY), a Cambridge, MA-based RNAi therapeutics company, is to receive up to $2 billion financing from

About Alnylam Pharmaceuticals Inc Alnylam Pharmaceuticals, Inc. operates as an early-stage therapeutics company. The Company discovers and develops drug and medicines for the treatment of human

Vid senaste bokslut 2019 hade företaget en omsättningsförändring på 92,2%. Fördelningen i styrelsen är 100,0 % män (1), 0,0 % kvinnor (0) . Ansvarig är Jan Peder Westerblad 53 år. På Ratsit hittar du Telefonnummer Adress Årsredovisning m.m. Alltid uppdaterat. 2021-04-06 · ExodusPoint Capital Management LP purchased a new position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) in the fourth quarter, Holdings Channel reports.

Alnylam

Latest Share Price and Events. Stable Share Price: ALNY is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 7% a week. 2020-04-13 2020-08-16 Alnylam is executing on its "Alnylam 2020" strategy of building a multi-product, commercial-stage biopharmaceutical company with a sustainable pipeline of RNAi-based medicines to address the needs of patients who have limited or inadequate treatment options. Alnylam is headquartered in Cambridge, MA. 2020-07-03 The following content may not be associated with Alnylam Pharmaceuticals. Links to all outside sites are provided as a reference for our visitors. Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals. 2020-04-27 2020-04-13 Everybody wins.

Alnylam Pharmaceuticals, Inc. Basdata; Relationstal; Jämför; Animation. Aktiekurs; P/E; P/B; Dividendavkasting. Hemland. Bransch, Biotechnology. Hembörs.

A number of other large investors have also recently bought and sold shares of ALNY. Amundi Pioneer Asset Management Inc. grew […] Alnylam is executing on its “Alnylam 2020” strategy of building a multi-product, commercial-stage biopharmaceutical company with a sustainable pipeline of RNAi-based medicines to address the needs of patients who have limited or inadequate treatment options.

ALNY | Complete Alnylam Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Alnylam Pharmaceuticals, Inc. Logo 4.4.

Links to all outside sites are provided as a reference for our visitors.
Göta landsväg stadsmuseet

Datum för upprättande. 2016-11-23. Antal anställda.

Spread, 1,14, Spread (%), 0.75%. Nattfinansiering - köp, -0.0555% Kliniska prövningar för Alnylam Pharmaceuticals. Registret för kliniska prövningar.
Flying cafe menu

2021-01-07

Onpattro | Alnylam's patisiran, the first ever FDA- and European . Alnylam pharmaceuticals inc alny: Börjar köpa in Novo Nordisk - Analys av aktie; Alnylam pharmaceuticals inc alny.

Saga garden holidays

Välkommen till Alnylam Policies. Att skydda din integritet och dina data är viktigt för oss. Vi är engagerade i företagens öppenhet för att hjälpa dig förstå vilken

We are based in Cambridge, MA with offices in … Learn about Alnylam Pharmaceuticals, RNAi therapeutics, and the company's efforts in treating amyloidosis, hyperoxaluria, and porphyria. Alnylam grundades 2002 och levererar en djärv vision om att förvandla vetenskapliga möjligheter till verklighet, med en robust forskningsplattform och flera läkemedel under utveckling i pipeline och två produkter som har godkänts i USA och Europeiska unionen.